Arkema has announced the launch of a commercial platform dedicated to 3D printing materials products.
Continuing its investment in the additive manufacturing market, which will see the opening of new facility and the expansion of another, Arkema will release new resins into North America and Asia through the next three years. PEKK resins will be launched in USA this year, photocure resins in China in 2019, and polyamide 11 biosourced resins will be available in Asia by 2021.
The company already provides photocure resins and high performance thermoplastic polymers through its N3xtDimension resins, Rilsan biosourced polyamides, and ultra-high performance Kepstan PEKK polymers brands, offering materials for the photocuring, powder bed fusion, and filament extrusion processes.
Arkema will leverage a number of strategic partnerships to supplement its own expertise and deliver to market these new materials products. Arkema will work closely with customers, partners and equipment manufacturers, as it aims to help transition 3D printing into a more viable option for manufacturing.
“Industry today needs flexibility, freedom of design, and product customisation,” commented Thierry Le Henaff, Chairman and CEO of Arkema. “With this commercial platform, Arkema will facilitate open communication and innovation across many product offerings and services, and will be in a position to support 3D printing market players as new applications are developed.”
Guillaume de Crevoisier, Global Business Director for the new commercial platform added: “3D Printing Solutions by Arkema will boost the Group’s positioning in this market and will help us, together with our partners, develop 3D printing into an industrial manufacturing technology.”